Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Orchestra BioMed Holdings (OBIO) Revenue (2022 - 2025)

Historic Revenue for Orchestra BioMed Holdings (OBIO) over the last 4 years, with Q3 2025 value amounting to $861000.0.

  • Orchestra BioMed Holdings' Revenue fell 1276.6% to $861000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.8 million, marking a year-over-year increase of 646.01%. This contributed to the annual value of $2.6 million for FY2024, which is 442.03% down from last year.
  • Per Orchestra BioMed Holdings' latest filing, its Revenue stood at $861000.0 for Q3 2025, which was down 1276.6% from $836000.0 recorded in Q2 2025.
  • Orchestra BioMed Holdings' 5-year Revenue high stood at $1.2 million for Q1 2023, and its period low was $253000.0 during Q4 2024.
  • For the 4-year period, Orchestra BioMed Holdings' Revenue averaged around $766400.0, with its median value being $861000.0 (2025).
  • Per our database at Business Quant, Orchestra BioMed Holdings' Revenue plummeted by 7624.66% in 2023 and then surged by 13556.09% in 2024.
  • Over the past 4 years, Orchestra BioMed Holdings' Revenue (Quarter) stood at $1.1 million in 2022, then tumbled by 76.25% to $262000.0 in 2023, then fell by 3.44% to $253000.0 in 2024, then soared by 240.32% to $861000.0 in 2025.
  • Its Revenue stands at $861000.0 for Q3 2025, versus $836000.0 for Q2 2025 and $868000.0 for Q1 2025.